Tech Company Financing Transactions
Hsiri Therapeutics Funding Round
Hsiri Therapeutics, based in Media, secured $70 thousand in investment from BioAdvance Ventures.
Transaction Overview
Company Name
Announced On
12/31/2015
Transaction Type
Venture Equity
Amount
$70,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1400 N. Providence Rd. Building 1 115S
Media, PA 19063
USA
Media, PA 19063
USA
Phone
Website
Email Address
Overview
Hsiri Therapeutics, LLC was formed in early 2012. The Company's primary focus is to develop new therapies for serious infectious diseases. Towards this end, the Company has several development assets that address important infectious diseases in both the developed and the developing world.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Claypool
Chief Financial Officer
Ivan Joseph
Chief Operating Officer
Carrie Frey
Chief Scientific Officer
Marvin Miller
Browse more venture capital transactions:
Prev: 12/31/2015: MedSocket venture capital transaction
Next: 12/31/2015: Keystone Dental venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. All VC database entries reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs